StonvexLoading…
StonvexStonvexStonvexCore line items from ABNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.68B | $12.24B | $9.46B | $5.37B |
Operating Income | $86.00M | $2.54B | $2.27B | $650.00M |
Net Income | $160.00M | $2.51B | $2.17B | $642.00M |
EPS (Diluted) | $0.26 | $4.03 | $3.47 | $1.27 |
Total Assets | $26.83B | $22.21B | $23.06B | $26.99B |
Total Liabilities | $19.19B | $14.01B | $14.45B | $19.21B |
Cash & Equivalents | $7.04B | $6.56B | $7.53B | $7.40B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 608.00M | 623.00M | 626.00M | 629.00M |